Needham & Company Maintains a 'Hold' on King Pharma (KG); FDA Ad Com Crushes Acurox, Adding Further Skepticism About Ultimate Approvability
Tweet Send to a Friend
Needham & Company maintains a 'Hold' on King Pharmaceuticals (NYSE: KG).
Needham analyst says, "Given the panel’s outcome, we are removing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "Given the panel’s outcome, we are removing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
